NCT00234754

Brief Summary

Stress urinary incontinence (SUI) is a health concern for many women. The transvaginal tape (TVT) surgery has become a common procedure to address the problem. Another surgery is now available, trans-obturator tape (TOT). The investigators will compare these 2 approaches to dealing with SUI and follow the women for 1 year. Women will also be followed at 5 years after surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
199

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2005

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2005

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 5, 2005

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 7, 2005

Completed
8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2013

Completed
Last Updated

August 31, 2016

Status Verified

August 1, 2016

Enrollment Period

8.1 years

First QC Date

October 5, 2005

Last Update Submit

August 29, 2016

Conditions

Keywords

IncontinenceSurgeryTrans-vaginal tapeTrans-obturator tape

Outcome Measures

Primary Outcomes (2)

  • How effective is TOT compared to TVT in terms of objective cure at 12 months postoperatively?

    Objective evidence of SUI will be obtained using a standardised pad test undertaken at 12 months following surgery. The pad test will be carried out using a modification of the International Continence Society (ICS) recommendations. Women will be considered 'cured' if the pad weight gain is less than 1g over the test period. This is the definition of cure used by Ward and will allow comparison with that trial.

    1 year

  • Vaginal erosion or other serious adverse outcomes of surgery over 5 years postoperatively

    5 years

Secondary Outcomes (12)

  • How effective is TOT compared to TVT in terms of subjective cure 12 months postoperatively?

    1 year

  • Incontinence-specific quality of life at 6 weeks and 12 months postoperatively?

    1 year

  • Satisfaction with surgery at 12 months postoperatively?

    1 year

  • Return to usual activities and usual sex life after surgery?

    6 weeks and 1 year

  • The prevalence of voiding dysfunction at 12 months postoperatively?

    1 year

  • +7 more secondary outcomes

Study Arms (2)

1

ACTIVE COMPARATOR

Trans-vaginal tape Surgery

Procedure: TVT Surgery TOT Surgery

2

EXPERIMENTAL

Trans-obturator tape surgery

Procedure: TVT Surgery TOT Surgery

Interventions

TVT surgery and TOT surgery

12

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women with type II stress incontinence, defined as leaking with increased abdominal pressure
  • Are eligible for both types of surgery

You may not qualify if:

  • Have vaginal prolapse requiring surgical repair
  • Have had previous incontinence surgery
  • Have overactive bladder or incontinence is caused only by bladder overflow
  • Intend to have further children
  • Have Alzheimer's or Parkinson's disease, progressive neurological disease such as multiple sclerosis, or are immunocompromised
  • Are unable to understand English
  • Will be unavailable for follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Calgary Health Region

Calgary, Alberta, T2N 2T9, Canada

Location

Related Publications (5)

  • Ross S, Robert M, Lier D, Eliasziw M, Jacobs P. Surgical management of stress urinary incontinence in women: safety, effectiveness and cost-utility of trans-obturator tape (TOT) versus tension-free vaginal tape (TVT) five years after a randomized surgical trial. BMC Womens Health. 2011 Jul 22;11:34. doi: 10.1186/1472-6874-11-34.

    PMID: 21781314BACKGROUND
  • Ross S, Robert M, Swaby C, Dederer L, Lier D, Tang S, Brasher P, Birch C, Cenaiko D, Mainprize T, Murphy M, Carlson K, Baverstock R, Jacobs P, Williamson T. Transobturator tape compared with tension-free vaginal tape for stress incontinence: a randomized controlled trial. Obstet Gynecol. 2009 Dec;114(6):1287-1294. doi: 10.1097/AOG.0b013e3181c2a151.

  • Lier D, Ross S, Tang S, Robert M, Jacobs P; Calgary Women's Pelvic Health Research Group. Trans-obturator tape compared with tension-free vaginal tape in the surgical treatment of stress urinary incontinence: a cost utility analysis. BJOG. 2011 Apr;118(5):550-6. doi: 10.1111/j.1471-0528.2010.02845.x. Epub 2011 Feb 4.

  • Ross S, Tang S, Eliasziw M, Lier D, Girard I, Brennand E, Dederer L, Jacobs P, Robert M. Transobturator tape versus retropubic tension-free vaginal tape for stress urinary incontinence: 5-year safety and effectiveness outcomes following a randomised trial. Int Urogynecol J. 2016 Jun;27(6):879-86. doi: 10.1007/s00192-015-2902-7. Epub 2015 Dec 15.

  • Lier D, Robert M, Tang S, Ross S. Surgical treatment of stress urinary incontinence-trans-obturator tape compared with tension-free vaginal tape-5-year follow up: an economic evaluation. BJOG. 2017 Aug;124(9):1431-1439. doi: 10.1111/1471-0528.14227. Epub 2016 Aug 10.

MeSH Terms

Conditions

Urinary Incontinence, Stress

Condition Hierarchy (Ancestors)

Urinary IncontinenceUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Sue Ross, PhD

    University of Calgary

    PRINCIPAL INVESTIGATOR
  • Magali Robert, MD

    Univerty of Calgary, Calgary Health Region

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Adjunct Professor, Obstetrics and Gynecology

Study Record Dates

First Submitted

October 5, 2005

First Posted

October 7, 2005

Study Start

September 1, 2005

Primary Completion

October 1, 2013

Study Completion

October 1, 2013

Last Updated

August 31, 2016

Record last verified: 2016-08

Locations